from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0897c/-

LFCtreatmentdescriptionclass of inhibitor

0.117

Amikacinug/mL Amikacintranslation

-0.807

Cap5-10ug/mL Capreomycintranslation

-0.308

Rox10-50 ug/mL Roxithromycintranslation

0.125

SM2-5 ug/mL Streptomycintranslation

-0.403

Tet5-10 ug/mL Tetracyclinetranslation

-0.330

Rif0.2-5ug/mL Rifampicintranscription

0.403

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.318

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.175

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.004

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.043

Clofazimine10-13 ug/mL Clofaziminerespiration

0.015

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.164

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.410

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.039

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.032

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.122

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.101

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.585

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.995

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.699

KCN5-20 ug/mL Potassium cyaniderespiration

0.695

NaN30.2-2 mM Sodium aziderespiration

-0.763

Nigericin50 uM Nigericinrespiration

0.682

TRC10-150 ug/mL Triclosanrespiration

-0.476

TRZ10-25 ug/mL Thioridazinerespiration

-0.855

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.672

menadione6-10 ug/mL Menadionerespiration

-0.032

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.617

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.336

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.298

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.164

NRP_1Non-replicating persistence stage 1dosRassociated

-0.454

Amp0.2mg/mL AmpicillincellWall

0.031

Cephalexin20-100 ug/mL CephalexincellWall

-0.350

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.713

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.372

EMB10-20 ug/mL EthambutolcellWall

0.158

Eta12-40 ug/mL EthionamidecellWall

0.268

INH0.2-0.4 ug/mL IsoniazidcellWall

0.226

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.098

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.443

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.444

BZA0.12 mg/mL BenzamidearomaticAmides

0.022

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.077

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.936

H2O24 mM hydrogen peroxideDNAdamaging

0.301

Levo10 ug/mL LevofloxacinDNAdamaging

-0.301

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.472

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.308

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.240

UVUV-irradiationDNAdamaging

-1.100

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.271

Antimycin12.5-50 ug/mL Antimycin A?

-0.864

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.286

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.359

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.518

PA8240.2-2 ug/mL PA-824?

1.260

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.261

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.705

Verapamil50 uM Verapamil?

-0.210

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.284

methoxatin10-20 ug/mL Methoxatin?